Education
About Us
Working with TipRanks
Follow Us
Allurion Technologies (ALUR)
NYSE:ALUR
ALUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.15 - $98.75
Previous CloseN/A
Volume63.90K
Average Volume (3M)2.90M
Market Cap
$19.08M
Enterprise Value$50.37M
Total Cash (Recent Filing)$9.94M
Total Debt (Recent Filing)$73.99M
Price to Earnings (P/E)―
Beta3.76
Next Earnings
May 20, 2025EPS Estimate
-1.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.74
Shares Outstanding5,961,714
10 Day Avg. Volume8,112,237
30 Day Avg. Volume2,902,327
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.37
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap2.64
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.21
Enterprise Value/Ebitda-2.81
Forecast
1Y Price Target
$10.63Price Target Upside232.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Bulls Say, Bears Say
Bulls Say
Product DevelopmentALUR has announced favorable initial results for the combination of the Allurion Program and low-dose GLP-1s.
Regulatory ApprovalThe Allurion Balloon has been cleared to resume sales in France, removing a major overhang on the international business.
Strategic InitiativesAllurion Technologies, Inc. is reorganizing its sales and marketing teams, hiring new representatives, and establishing new relationships with distributors, indicating a strategic push for growth.
Bears Say
Financial PerformanceSales of $5.6MM were below the estimate of $6.5MM, indicating underperformance.
Market ValuationThe price target for Allurion Technologies, Inc. has been significantly lowered to $6 from the previous $16, reflecting a recent contraction in small-cap valuations.
Revenue DeclineThere was a 32% year-over-year decline in 4Q'24 revenue, primarily due to a temporary suspension of sales in France and macroeconomic headwinds affecting re-order rates.
---
Ownership Overview
17.02% Insiders
26.31% Mutual Funds
― Other Institutional Investors
82.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ALUR FAQ
What was Allurion Technologies’s price range in the past 12 months?
Allurion Technologies lowest stock price was $2.15 and its highest was $98.75 in the past 12 months.
What is Allurion Technologies’s market cap?
Allurion Technologies’s market cap is $19.08M.
When is Allurion Technologies’s upcoming earnings report date?
Allurion Technologies’s upcoming earnings report date is May 20, 2025 which is in 51 days.
How were Allurion Technologies’s earnings last quarter?
Allurion Technologies released its earnings results on Mar 26, 2025. The company reported -$7.95 earnings per share for the quarter, missing the consensus estimate of -$5.697 by -$2.253.
Is Allurion Technologies overvalued?
According to Wall Street analysts Allurion Technologies’s price is currently Undervalued.
Does Allurion Technologies pay dividends?
Allurion Technologies does not currently pay dividends.
What is Allurion Technologies’s EPS estimate?
Allurion Technologies’s EPS estimate is -1.57.
How many shares outstanding does Allurion Technologies have?
Allurion Technologies has 5,961,714 shares outstanding.
What happened to Allurion Technologies’s price movement after its last earnings report?
Allurion Technologies reported an EPS of -$7.95 in its last earnings report, missing expectations of -$5.697. Following the earnings report the stock price went up 0.322%.
Which hedge fund is a major shareholder of Allurion Technologies?
Currently, no hedge funds are holding shares in ALUR
---
Allurion Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.63 (232.19% Upside)
$10.63 (232.19% Upside)
Blogger Sentiment
Bullish
ALUR Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 51.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 14.5%
Last 30 Days ▲ 14.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.68%
12-Months-Change
Fundamentals
Return on Equity
38.80%
Trailing 12-Months
Asset Growth
-54.24%
Trailing 12-Months
Company Description
Allurion Technologies
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
---
ALUR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with key achievements in procedure volume growth, successful combination therapy results, and operational restructuring leading to reduced expenses. However, these were countered by significant revenue and gross profit margin declines, as well as a notable loss from operations.Read More>---
ALUR Stock 12 Month Forecast
Average Price Target
$10.63
▲(232.19% Upside)
Technical Analysis
NovoCure
―
Tactile Systems Technology
―
Irhythm Technologies
―
Inspire Medical Systems
―
Butterfly Network
―
Best Analysts Covering ALUR
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-53.68%
reiterated a buy rating 5 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -53.68% per trade.
---